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Objectives: Protein and energy malnutrition and unintended weight loss are frequently reported in pa-
tients with mild cognitive impairment (MCI) and Alzheimer’s disease (AD). Possible underlying mech-
anisms include increased energy expenditure, altered uptake of nutrients, a reduced nutritional intake, or
a combination of these 3. We aimed at systematically reviewing the literature to examine potential
differences in energy and protein intake in patients with MCI and AD compared to controls as a possible
mechanism for unintended weight loss.
Design: Systematic review and meta-analysis.
Setting: PubMed and Cochrane Electronic databases were searched from inception to September 2017 for
case control studies.
Participants: Patients with MCI or AD compared to cognitive healthy controls, all adhering to a Western
dietary pattern.
Measurements: Energy and protein intake.
Results: The search resulted in 7 articles on patients with AD versus controls, and none on patients with
MCI. Four articles found no differences in energy and protein intakes, 1 found higher intakes in patients
with AD, and 1 article found lower intakes in patients with AD compared to controls. One article reported
on intakes, but did not test differences. A meta-analysis of the results indicated no difference between
patients with AD and controls in energy [8 kcal/d, 95% confidence interval (CI): 97, 81; P ¼ .85], or
protein intake (2 g/d, 95% CI: 4, 9; P ¼ .47). However, heterogeneity was high (I2 > 70%), and study
methodology was generally poor or moderate.
Conclusion: Contrary to frequently reported unintended weight loss, our systematic review does not
provide evidence for a lower energy or protein intake in patients with AD compared to
controls. High heterogeneity of the results as well as of participant characteristics, setting, and
study methods was observed. High-quality studies are needed to study energy and protein intake
as a possible mechanism for unintended weight loss and malnutrition in both patients with
MCI and AD.
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A.S. Doorduijn et al. / JAMDA 20 (2019) 14e21 15Alzheimer’s disease (AD) is a progressive neurodegenerative dis-
ease, characterized by progressive deterioration in cognitive func-
tioning resulting in interference with daily functioning.1 In the early
stage of the disease, patients experience cognitive complaints in (most
often) 1 or 2 functions, while the ability to take care of themselves
remains intact.With progression of the disease, patients becomemore
and more dependent on their caregivers, and in the final stage insti-
tutionalization is almost unavoidable.
An estimated number of almost 50 million people worldwide
suffer from dementia and theWorld Health Organization predicts that
the number of people will reach 131 million in 2050.2 To date, there is
neither an effective curative treatment, nor one that slows down the
progression of the disease.
AD is the cause of more than 70% of dementia cases.2 The phase
between cognitive changes due to normal aging and the first clinical
features of dementia is called mild cognitive impairment (MCI). Pa-
tients withMCI experience a decline in cognition, mostlymemory, but
their daily functioning is still intact.3
Patients withMCI and AD often suffer fromweight loss and protein
and energy malnutrition, with reported prevalence ranging between
20% and 50%,4e8 depending on the methods used and the severity of
the disease stage. Patients in more advanced stages of AD are more
often unable to feed themselves and/or might suffer from dysphagia,
hindering adequate intake.9 Unintended weight loss and malnutrition
have been associated with an accelerated progression of the disease, a
higher rate of institutionalization, and increased mortality.10,11 The
mechanisms underlying unintended weight loss and increased risk of
malnutrition are not yet clear.
Several mechanisms that could contribute to the observed
malnutrition and weight loss have been proposed.12,13 The first
mechanism could be a disbalance between energy expenditure and
energy intake, because of an increased energy expenditure in the
patient with AD.13 However, no differences between patients with AD
and healthy older adults in measured daily energy expenditure,
adjusted for body composition, were observed in a previous study.14
Another study found no differences in physical activity between pa-
tients with AD compared to healthy control subjects matched for age,
gender, and body mass index (BMI).15 An increased energy expendi-
ture as possible mechanism underlying weight loss and malnutrition
seems unlikely based on these 2 studies; however, more research is
clearly needed. As a second proposed mechanism, patients with AD
might have a less efficient uptake of nutrients, leading to malnutri-
tion.13 This mechanism has rarely been studied and is mostly related
to deficiencies in vitamins and minerals rather than protein and en-
ergy malnutrition.12,16 Lastly, patients with AD might have a lower
nutritional intake, caused by reduced appetite, smell, or taste. Little is
known about the nutritional intake of patients with MCI and AD
compared to controls. Therefore, we systematically reviewed the
literature for observational studies providing data on the actual en-




A systematic literature search was performed in accordance with
Preferred Reporting Items for Systematic Review and Meta-Analyses
(PRISMA).17 The bibliographic database PubMed and the Cochrane
database were searched from inception to September 5, 2017. We
searched for articles that reported the actual energy and protein
intake in patients with MCI or AD compared to controls, using a
combination of MeSH and text-based terms.
(“Dementia” [MeSH] OR “Alzheimer” [MeSH] OR “mild cognitive
impairment” [MeSH]) AND (“energy intake” [Title/Abstract] OR“protein intake” [Title/Abstract] “nutritional intake” [Title/Abstract]
OR “nutrition*” [Title/Abstract] OR “dietary intake” [Title/Abstract] OR
“food intake” [Title/Abstract] OR “eating habit” [Title/Abstract] OR
“diet” [Title/Abstract]) AND ("Adult"[Mesh] OR adult*[Title/Abstract]).
Additionally, reference lists of identified manuscripts and reviews
were checked manually.
Criteria for Inclusion
Only articles with a case-control design reporting on energy and/or
protein intake in patients with MCI or AD compared with cognitively
normal controls were included. Participants should adhere to a
Western dietary pattern, and publications had to be written in English
and to be available in full-text.
Criteria for Exclusion
Articles were excluded if they focused on specific subgroups of
patients with MCI or AD, for example, those with significant weight
loss or those on a semisolid or liquid diet. Articles that focused on the
role of nutrition in the development of dementia were also excluded.
Study Selection Process
The search strategy identified 800 articles, which were screened
on title and abstract by 2 authors independently. Screening resulted in
136 articles eligible for full-text screening. One additional article was
found via the reference list of an included article.15 Finally, 7 articles
were included based on abstract and full text (Figure 1).
Quality Assessment of the Studies
The Newcastle-Ottawa Scale (NOS) for case-control studies18 was
used to assess the methodological quality of the included papers. The
following criteria were scored: definition of cases, representativeness
of cases, selection of controls, definition of controls, comparability of
cases and controls on age and gender, nutritional intake method, and
using the same methodology in both groups.18 The more criteria were
met, the higher the score and the better the methodological quality.
Two authors independently assessed the quality of the studies; dis-
agreements were solved by a third author. A study was considered to
have poor methodological quality when the score of the scale was
below 5 of 8 criteria.
Data Extraction
From the selected articles, the following information was extrac-
ted: number of participants per group, selection criteria for control
group, diagnostic criteria used, study setting, Mini-Mental State Ex-
amination (MMSE19) score, mean age, percentage female, anthro-
pometry (BMI or body weight), feeding difficulties, nutritional status,
nutritional intake assessment method, results of energy (kilocalories
per day) and protein (grams per day) intake per group.
Of 3 articles using a different unit of energy intake, energy intake
was recalculated to kilocalories per day.15,20,21 Two studies20,21 re-
ported the energy and protein intake per kilogram body weight. As we
were unable to contact the authors, we recalculated the intake by
multiplying the reported intake in kilocalories or grams per kilogram
body weight by the mean body weight of the study sample.
Meta-analysis
Random effects meta-analyses were performed to estimate the
mean energy and protein intakes across the selected articles.22 Results
are presented as forest plots. The Cochrane c2 was used to test the
Fig. 1. Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) flow diagram for the study selection process.
A.S. Doorduijn et al. / JAMDA 20 (2019) 14e2116presence of heterogeneity across the included articles, a P < .05 was
considered as indicative of heterogeneity. The degree of heterogeneity
was evaluated using I2, with values of 25%, 50% and 75% indicating low,
moderate and high degrees of heterogeneity respectively.23 The ana-
lyses were performed using Review Manager 5 (version 5.3, The
Cochrane Collaboration, Copenhagen, Denmark). Six studies were
included in the meta-analysis on energy intake, Spindler20 could not
be included since only median values and interquartile ranges were
reported. Five studies reported on protein intake and were included in
the meta-analysis on protein intake. The meta-analyses was stratified
by disease severity; severe dementia (MMSE score 18) versus mild
dementia (MMSE score >18).24 Stratification was also performed us-
ing 3 groups: severe dementia (MMSE score 0-7), moderate dementia
(MMSE score 8-14), and mild dementia (MMSE score 15-23).25
Results
Table 1 summarizes the 7 articles included in this review. Four
articles were based on data collected in European countries (United
Kingdom,27 Finland,28 Italy,21 and France29), 2 collected data in the
USA,15,20 and 1 in Canada.26 Four articles were based on data from
community-dwelling patients with AD,15,26e28 and 3 on data from
institutionalized patients with AD.20,21,29 No articles focusing on pa-
tients with MCI were found. Sample size ranged from 4020 to 34629
participants. The mean MMSE score of the cases ranged from 1121 to
24,26 and of the controls from 2521 to 30.26,27 The mean age of theparticipants ranged from 7220 to 8821 years, with 31%28 to 91%21
women. In the study population of Franzoni,21 45% needed total
assistance with feeding; in all other articles, cases and controls did not
have problems with feeding themselves. In the study of Jesus,29 both
cases and controls had nutritional difficulties (changes in weight or
appetite) as assessed by a General Practitioner, and both groups were
at risk for malnutrition. The patients with AD in the study of Sha-
tenstein26 were more likely to be at moderate risk for malnutrition
compared to controls. The patients with AD in the study of Dvorak15
had lost on average 4.1 kg body weight, in the past year and in the
study of Puranen, 51% of the female and 40% of the male AD patients
were at risk for malnutrition. The other 2 articles20,27 did not provide
information on the nutritional status of their participants. Two articles
did not specify the type of dementia.21,29 Controls consisted of spou-
ses,27,28 residents who did not have dementia,21,29 or age- and BMI-
matched community-dwelling individuals.15,20,26 Four studies used a
3- or 4-day food diary to estimate nutritional intake,15,20,27,28 1 used 2
nonconsecutive 24-hour recalls,26 2 studies weighed the food that was
consumed by the participants,20,21 and 1 used a 3-day survey of food
intake by paramedical personnel.29 Except for Spindler,20 all studies
used the same nutritional intake assessment method in both groups.
Quality Assessment of the Studies
Table 2 presents the assessment of methodological quality. Two
studies had a high methodological quality, scoring 7 of 8 points,15,21
Table 1
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1527  364 64  19
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No information No information 1810  370
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26  3y 88  7 83 BMI: 26.3  7.5 Poor to moderate
nutritional status,
based on MNAx





(1.0  0.4 g/kg
BW*)
e, not in text; BW, body weight; DSM, Diagnostic and Statistical Manual of Mental Disorders; F, female; M, male; MJ, megajoules; NINCDS-ADRDA, National Institute of Neurological and Communicative Disorders and Stroke and
the Alzheimer’s Disease and Related Disorders Association.
All data are in mean  SD or median [95% CI], Numbers in italic were recalculated.
*P < .01 vs AD.
yP < .001 vs AD.
zENS ¼ Elderly Nutrition Screening (0-2 ¼ low risk; 3-5 ¼ moderate risk; 6þ ¼ high risk).

















Methodological Quality of the 7 Included Articles Assessed Using the Newcastle Ottawa Scale for Case Control Studies17
Author Selection Comparability Exposure Score
Definition of
Cases






Same Method Total (Max 8)
Shatenstein26 þ  þ þ   þ þ 5
Dvorak15 þ þ þ  þ þ þ þ 7
Spindler20 þ þ     þ  3
Tabet27 þ þ  þ þ þ  þ 6
Puranen28 þ þ      þ 3
Franzoni21 þ þ þ  þ þ þ þ 7
Jesus29   þ  þ þ  þ 4
þ, quality criterion met; , quality criterion not met.
*Quality of the nutritional intake assessment method used.
A.S. Doorduijn et al. / JAMDA 20 (2019) 14e21 19and 2 studies had a moderate methodological quality,26,27 scoring 5
and 6 points. The 3 studies20,28,29 with poor methodological quality
(less than 5 points) particularly performed poorly on control selection,
definition of controls, and the comparability of cases and controls.
Quantitative Analysis
Three articles found no difference in energy and protein intake
between patients with AD and controls. Tabet27 found no differences
in total energy and protein intake, but did observe differences in in-
takes expressed per kilogram of body weight. One article found a
lower energy and protein intake in patients with AD compared to
controls,26 whereas another article found a higher energy and protein
intake in patients with AD.20 Puranen reported energy and protein
intake in patients with AD compared to their spouses, but did not test
the differences.28 In patients with or at risk of malnutrition, 1 study
found a higher nutritional intake,28 2 studies found no difference in
intake,15,29 and another study reported a lower nutritional intake26
compared to controls.
Meta-analysis was used to combine study results. Forest plots
(Figure 2) indicate mean differences in energy (A) and protein (B)
intake between patients with AD and controls.Fig. 2. Forest plots of energy intake in kilocalories per day (A) and protein (B) intaThe overall mean intakes did not differ between patients with AD
and controls for energy [6 studies, mean difference (MD): 8 kcal/d,
95% confidence interval (CI): 97, 81; P ¼ .85], and protein (5 studies,
MD: 2 g/d, 95% CI: 4, 9; P ¼ .47). Heterogeneity was high for both
outcomemeasures (I2¼ 73%, P¼ .003; I2¼ 75%, P¼ .003, respectively).
Leaving out the 3 studies with poor methodological quality did not
significantly change the results of both energy (4 studies,
MD: 81 kcal/d, 95% CI: 213, 51; P ¼ .23) and protein intake (2
studies, MD: 5 g/d, 95% CI: 16, 5; P ¼ .30), with moderate to high
heterogeneity (I2 of 69% and 58%, respectively).
Stratification of the results by disease severity based on the review
of Tombaugh (severe dementia: mean MMSE score 17, 3 studies for
energy and protein andmoderate dementia: meanMMSE score>18, 3
studies for energy and 2 studies for protein) did not significantly
change the results of energy intake (severe dementia: MD: 19 kcal/d,
95% CI: 49, 88; P ¼ .58; moderate dementia: MD: 20 kcal/d, 95%
CI:195,155; P¼ .83) and protein intake (severe dementia:MD: 6 g/d,
95% CI: 2, 13; P ¼ .12; moderate dementia: MD: 2 g/d, 95% CI: 17,
13; P ¼ .77). Stratification of the results by disease severity based on
the article of Kreamer [severe dementia (MMSE score 0-7), no studies,
moderate dementia (MMSE score 8-14), 2 studies for energy and
protein and mild dementia (MMSE score 15-23), 3 studies for energyke in grams per day of AD patients compared to cognitively normal controls.
A.S. Doorduijn et al. / JAMDA 20 (2019) 14e2120and 1 study for protein] did not significantly change the results of
energy intake (moderate dementia: MD: 8 kcal/d, 95% CI: 106, 122;
P ¼ .89; mild dementia: MD: 54 kcal/d, 95% CI: 54, 161; P ¼ .23) and
protein intake (moderate dementia: MD: 4 g/d, 95% CI: 0, 7; P ¼ .05;
mild dementia not possible, only 1 study).
Stratification of the results by study setting did not significantly
change the results of either energy (institution, 2 studies, MD: 8 kcal/
d, 95% CI: 106, 122; P ¼ .89; community, 4 studies, MD: 16 kcal/d,
95% CI: 156, 124; P ¼ .82) or protein intake (institution, 3 studies,
MD: 6 g/d, 95% CI: 2, 13; P ¼ .12; community, 2 studies, MD: 2 g/d,
95% CI: 17, 13; P ¼ .77).
Discussion
We found 7 articles in this literature search reporting energy and/
or protein intake of patients with AD versus controls, but none
reporting the intakes of patients with MCI. The studies varied in
participant characteristics, selection of controls, setting and nutri-
tional intake assessment method, and oftenwere of poor or moderate
methodological quality. The main finding of this study is that the
available literature does not provide evidence for a lower energy and
protein intake of patients with AD versus controls.
The included articles differed in participant characteristics (age,
gender, MMSE score), study setting, and nutritional intake assessment
method. For example, the MMSE scores in the patients with AD and
controls varied but overlapped between the groups, which may have
influenced the results. The MMSE score of patients with AD ranged
from 11 to 24, covering both moderate and severe disease stages.
Stratification of the meta-analyses in 2 subgroups by disease stage did
not significantly change the results and suggests there is no difference
in nutritional intake between different disease stages. Stratification of
the meta-analyses in 3 subgroups was difficult to interpret because of
the limited number of studies in each stratum. In 2 articles,27,28 pa-
tients were compared with their spouses and were therefore always
compared with someone from the opposite gender. As men are likely
to eat more energy and protein per day than women,30 such a com-
parison might introduce bias. Because of the high degree of hetero-
geneity across articles, results of our meta-analysis should be
interpreted with caution.
In the studies conducted in institutionalized patients, consumed
food was weighed20,21 or the food intake was recorded by care pro-
fessionals during 3 days, requiring no participation of the patients or
controls.29 In the studies conducted in community-dwelling patients,
the most commonly used method to assess nutritional intake was a 3-
or 4-day food diary, or two 24-hour recalls.15,20,26,27 These methods
rely on thememory of the participant. It is not known how valid a food
diary or two 24-hour recalls are to estimate nutritional intake in
populations with dementia. There is a clear need for validation of
nutritional assessment methods in this particular group of
patients.31e33
This study has some limitations. First of all, the high heterogeneity
across articles makes it hard to compare studies and to draw conclu-
sions. Across the articles, different units of energy and protein intake
were used. As the majority of the results was expressed in absolute
numbers and not all articles described the mean body weight of their
participants, we decided to recalculate nutritional intake by multi-
plying the reported intake in kilocalories or grams per kilogram body
weight by the mean body weight of the study sample. We are, how-
ever, aware of the limitations by reporting data on nutritional intake
this way, and adjustment for body weight and/or physical activity
level would have been preferred. Only 1 study reported data on ac-
tivity level, which made it impossible to consider physical activity
level in the comparison of nutritional intakes between patients and
controls. Because of the observational design of the studies, where
food intakewasmeasured at onemoment in time, wewere not able tostudy a possible decline in food intake or changes in nutritional status
or body weight over time. Furthermore, cases and controls were not
always comparable, especially not in the study of Spindler, because
cases and controls lived in different settings. No difference in nutri-
tional intake was found after stratification of the meta-analysis by
study setting, that is, institution versus community. However, the
number of studies included per group after stratification was very
small.
Only 2 studies scored 7 of 8 points on the Newcastle Ottawa Scale
for quality assessment for case-control studies, indicating good
methodologic quality. Both studies, 1 in community-dwelling patients
with energy intake expressed in kilocalories per day and 1 in insti-
tutionalized patients with energy and protein expressed per kilogram
body weight, found no differences in intake between patients and
controls.15,21 Other articles scored lower on methodologic quality,
most often because the controls were not comparable to the cases.
Summarizing, results of this review based on 7 articles suggest no
lower energy and protein intake of patients with AD compared to
controls. No articles comparing the intakes of patients with MCI
versus controls were found. Because of the high degree of heteroge-
neity across studies, the limited number of included studies, and their
poor to moderate methodologic quality, these results should be
interpreted with caution. High-quality research is needed to obtain
more insight into the role of low protein and energy intake as a
possible mechanism for weight loss and malnutrition in patients with
AD. Furthermore, we recommend studies in patients with MCI, as this
might give useful information on the earliest changes in nutritional
intake, even before the diagnosis of AD.References
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